Product Description
Maxiflo 250 Inhaler is a pharmaceutical-grade inhalation therapy designed for adults and adolescents aged 12 years and above. This inhaler, containing Fluticasone Propionate and Salmeterol Xinafoate, is formulated to treat asthma and chronic obstructive pulmonary disease (COPD). With a recommended dosage of 1 or 2 inhalations twice daily, this medical-grade inhaler provides 250 mcg per puff. Stored below 30C away from direct sunlight and moisture, Maxiflo 250 Inhaler is ideal for maintaining respiratory health.
FAQs of Maxiflo 250 Inhaler:
Q: Who can use Maxiflo 250 Inhaler?
A: Maxiflo 250 Inhaler is suitable for adults and adolescents aged 12 years and above.
Q: What conditions can Maxiflo 250 Inhaler treat?
A: This inhaler is used for the treatment of asthma and chronic obstructive pulmonary disease (COPD).
Q: How should I store Maxiflo 250 Inhaler?
A: It is recommended to store the inhaler below 30C, protected from direct sunlight and moisture.
Q: What is the recommended dosage for Maxiflo 250 Inhaler?
A: The suggested dosage is 1 or 2 inhalations twice daily as prescribed by a healthcare professional.
Q: What are the key components of Maxiflo 250 Inhaler?
A: Maxiflo 250 Inhaler contains Fluticasone Propionate and Salmeterol Xinafoate as active ingredients.